Nafagrel (hydrochloride)
Nafagrel hydrochloride is a thromboxane A2 synthetase inhibitor. Nafagrel hydrochloride can prevent the accumulation of thrombus material in a rat model of acute arterial thrombosis[1][2].
Product Specifications
CAS Number
97901-22-9
UNSPSC
12352005
Target
Prostaglandin Receptor
Related Pathways
GPCR/G Protein
Field of Research
Cardiovascular Disease
Smiles
OC(C1=CC=C(CC(CN2C=CN=C2)CC3)C3=C1)=O.Cl
Molecular Formula
C15H17ClN2O2
Molecular Weight
292.76
References & Citations
[1]Geiger J. Inhibitors of platelet signal transduction as anti-aggregatory drugs. Expert Opin Investig Drugs. 2001 May;10 (5) :865-90. |[2]Bernat A, et al. Effect of various antiplatelet agents on acute arterial thrombosis in the rat. Thromb Haemost. 1993 Nov 15;70 (5) :812-6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC401200-500 1x 500 µL
EGFR (GFR1195 + 31G7), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
PKSV030182 100 µg
Recombinant HIV-1 (group M, subtype B, isolate BAL) gp120 Protein (His Tag)
Sign In for Pricing
View Details